|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61P 3/10 | |||
| A61P 19/02 | |||
| A61P 37/00 |
| (11) | Number of the document | 2825191 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13734483.4 |
| Date of filing the European patent application | 2013-03-14 | |
| (97) | Date of publication of the European application | 2015-01-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2013/001179 |
| Date | 2013-03-14 |
| (87) | Number | WO 2013/136193 |
| Date | 2013-09-19 |
| (30) | Number | Date | Country code |
| 201261612183 P | 2012-03-16 | US | |
| 201261646143 P | 2012-05-11 | US | |
| 201261731428 P | 2012-11-29 | US |
| (72) |
TUSCHE, Michael, W., US
MAK, Tak, W., CA
OHASHI, Pamela, S., CA
LANG, Philipp, DE
BRENNER, Dirk, CA
LIN, Gloria, CA
|
| (73) |
University Health Network,
190 Elizabeth Street R. Fraser Elliott Building, 1S-417, Toronto, ON M5G 2C4,
CA
|
| (54) | SOLUBLE TOSO PROTEIN AND ITS USE IN TREATING AUTOIMMUNE DISORDERS |
| SOLUBLE TOSO PROTEIN AND ITS USE IN TREATING AUTOIMMUNE DISORDERS |